Just in Time for Summer Sandal Season: Valeant’s Jublia® Approved for Onychomycosis
The US Food and Drug Administration (FDA) has approved Jublia® (efinaconazole 10% topical solution) for the treatment of onychomycosis of the toenails.
The US Food and Drug Administration (FDA) has approved Jublia® (efinaconazole 10% topical solution) for the treatment of onychomycosis of the toenails.
Engineered for implants up to 1500cc, the next-generation delivery system supports a “no-touch” technique to improve control, reduce friction, and minimize risks such as infection and capsular contracture.